MeSH term
Frequency | Condition_Probility | Adult | 34 | 0.0 |
Cohort Studies | 4 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 23 | 0.0 |
Humans | 171 | 0.0 |
Phenotype | 61 | 0.0 |
Protein-Tyrosine-Phosphatase/*genetics/metabolism | 2 | 9.0 |
*Proto-Oncogene Proteins | 14 | 0.0 |
Alleles | 35 | 0.0 |
Blood Group Antigens/*genetics | 9 | 8.0 |
Chi-Square Distribution | 8 | 1.0 |
Cluster Analysis | 2 | 1.0 |
Ethnic Groups/*genetics | 7 | 3.0 |
Gene Frequency | 45 | 0.0 |
Haplotypes | 5 | 0.0 |
*Polymorphism, Genetic | 36 | 0.0 |
Research Support, Non-U.S. Gov't | 65 | 0.0 |
Comparative Study | 25 | 0.0 |
Female | 89 | 0.0 |
Infant, Newborn | 19 | 0.0 |
Isoenzymes/*genetics | 14 | 3.0 |
Italy | 13 | 2.0 |
Male | 83 | 0.0 |
Pregnancy | 15 | 0.0 |
Protein-Tyrosine-Phosphatase/*genetics | 13 | 9.0 |
Reference Values | 3 | 0.0 |
Signal Transduction/*genetics | 6 | 4.0 |
Haptoglobins/*analysis | 3 | 23.0 |
English Abstract | 23 | 0.0 |
*Genetic Markers | 13 | 3.0 |
*Heterozygote | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
ABO Blood-Group System/*genetics | 2 | 4.0 |
Acid Phosphatase/genetics | 11 | 33.0 |
Erythrocytes/*enzymology | 39 | 7.0 |
Lactoylglutathione Lyase/genetics | 6 | 13.0 |
Phosphoglucomutase/genetics | 8 | 17.0 |
Russia | 9 | 9.0 |
Acclimatization/*genetics | 2 | 100.0 |
Adolescent | 10 | 0.0 |
Altitude | 2 | 8.0 |
Child | 18 | 0.0 |
Italy/epidemiology | 5 | 2.0 |
Models, Genetic | 4 | 0.0 |
Polymorphism, Genetic | 29 | 0.0 |
Acid Phosphatase/*genetics | 15 | 40.0 |
*Carboxylesterase | 10 | 9.0 |
*Gene Pool | 5 | 26.0 |
Geography | 3 | 4.0 |
Lactoylglutathione Lyase/*genetics | 3 | 7.0 |
Phosphoglucomutase/*genetics | 3 | 2.0 |
Phosphogluconate Dehydrogenase/*genetics | 2 | 16.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Middle Aged | 21 | 0.0 |
Phosphorylation | 3 | 0.0 |
Rome/epidemiology | 3 | 60.0 |
Analysis of Variance | 2 | 0.0 |
Birth Weight | 5 | 3.0 |
Case-Control Studies | 6 | 0.0 |
DNA/genetics | 3 | 0.0 |
Ethnic Groups/genetics | 2 | 1.0 |
Base Sequence | 5 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Adenosine Deaminase/*genetics | 4 | 17.0 |
Aged | 11 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Body Mass Index | 4 | 0.0 |
Electrophoresis, Starch Gel | 7 | 5.0 |
Hemoglobin A, Glycosylated/metabolism | 2 | 1.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
Enzymes/*genetics | 5 | 11.0 |
Genetic Markers/*genetics | 2 | 1.0 |
*Genetics, Population | 13 | 3.0 |
*Gene Frequency | 16 | 3.0 |
Indians, South American/*genetics | 2 | 3.0 |
Multivariate Analysis | 2 | 0.0 |
Peru | 2 | 4.0 |
Variation (Genetics) | 11 | 0.0 |
DNA Primers | 3 | 0.0 |
Paternity | 2 | 2.0 |
Chromosome Mapping | 18 | 0.0 |
Haptoglobins/*genetics | 2 | 5.0 |
*Phenotype | 2 | 0.0 |
Genetic Markers | 27 | 0.0 |
Spain | 7 | 2.0 |
*Variation (Genetics) | 7 | 0.0 |
Hemoglobins/genetics | 3 | 12.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Molecular Weight | 4 | 0.0 |
Africa/ethnology | 2 | 4.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Ecuador | 2 | 18.0 |
Emigration and Immigration | 2 | 4.0 |
Enzymes/genetics | 5 | 15.0 |
ABO Blood-Group System/genetics | 4 | 9.0 |
Acid Phosphatase/blood/genetics | 4 | 57.0 |
Haptoglobins/genetics | 4 | 8.0 |
Heterozygote | 3 | 0.0 |
Transferrin/genetics | 6 | 12.0 |
Vitamin D-Binding Protein/genetics | 3 | 11.0 |
Blood Glucose/*metabolism | 2 | 0.0 |
Pregnancy in Diabetics/enzymology/genetics | 2 | 100.0 |
Animals | 12 | 0.0 |
Erythrocytes/enzymology | 18 | 4.0 |
Genetics, Population | 3 | 0.0 |
Portugal | 2 | 3.0 |
Adenosine Deaminase/genetics | 6 | 27.0 |
Adenylate Kinase/genetics | 4 | 16.0 |
Carboxylic Ester Hydrolases/genetics | 6 | 20.0 |
Regression Analysis | 2 | 0.0 |
Complement 3/genetics | 3 | 8.0 |
Heterozygote Detection | 2 | 0.0 |
Venezuela | 2 | 6.0 |
*Alleles | 3 | 0.0 |
Gestational Age | 3 | 0.0 |
Adenosine Deaminase/blood/genetics | 2 | 50.0 |
Blood Proteins/*genetics | 10 | 6.0 |
Carboxylic Ester Hydrolases/blood/genetics | 2 | 40.0 |
Phosphogluconate Dehydrogenase/blood/genetics | 2 | 40.0 |
Blood Group Antigens/genetics | 7 | 11.0 |
Acid Phosphatase/*blood/genetics | 7 | 87.0 |
Pregnancy in Diabetics/*enzymology | 2 | 66.0 |
Carbonic Anhydrases/genetics | 2 | 22.0 |
Child, Preschool | 6 | 0.0 |
Infant | 6 | 0.0 |
Acid Phosphatase/*blood/*genetics | 2 | 100.0 |
Amino Acid Sequence | 6 | 0.0 |
Isoenzymes/blood/genetics | 6 | 35.0 |
Odds Ratio | 2 | 0.0 |
*Chromosomes, Human, Pair 2 | 4 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
European Continental Ancestry Group/*genetics | 3 | 0.0 |
*Linkage (Genetics) | 14 | 1.0 |
Blood Proteins/genetics | 4 | 7.0 |
Adenylate Kinase/*genetics | 3 | 13.0 |
Porphobilinogen Synthase/*genetics | 2 | 8.0 |
Acid Phosphatase/blood/*genetics | 14 | 73.0 |
Pedigree | 20 | 0.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
*Indians, South American | 3 | 13.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Rats | 2 | 0.0 |
Gene Frequency/genetics | 3 | 0.0 |
Lod Score | 5 | 0.0 |
Acid Phosphatase/genetics/*metabolism | 2 | 66.0 |
Cytosol/enzymology | 2 | 1.0 |
Kinetics | 3 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Aniridia/*genetics | 2 | 7.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
Chromosomes, Human, Pair 2 | 3 | 1.0 |
*Genes, Dominant | 3 | 1.0 |
Linkage (Genetics) | 11 | 0.0 |
Acid Phosphatase/chemistry/*genetics | 2 | 66.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Acid Phosphatase/*blood | 4 | 3.0 |
*Gene Expression Regulation | 2 | 0.0 |
*Pregnancy in Diabetics | 2 | 25.0 |
Karyotyping | 3 | 0.0 |
Adenosine Deaminase/blood/*genetics | 3 | 75.0 |
Brazil | 5 | 2.0 |
*Chromosome Mapping | 7 | 0.0 |
Mice | 2 | 0.0 |
Obesity/*enzymology/genetics | 2 | 100.0 |
*Jews | 2 | 4.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
European Continental Ancestry Group/genetics | 5 | 0.0 |
South Africa | 2 | 1.0 |
DNA Probes | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Hydrolases/*genetics | 2 | 8.0 |
Isoelectric Focusing | 7 | 1.0 |
Phosphogluconate Dehydrogenase/genetics | 2 | 7.0 |
Sex Factors | 4 | 0.0 |
Nucleoside Deaminases/*genetics | 4 | 26.0 |
Israel | 2 | 1.0 |
Heat | 2 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Electrophoresis, Agar Gel | 3 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Genes | 2 | 0.0 |
Japan | 2 | 0.0 |
Phosphoglucomutase/blood/*genetics | 2 | 9.0 |
Isoenzymes/*blood/genetics | 2 | 18.0 |
Enzymes/blood/*genetics | 2 | 33.0 |
Hamsters | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Phosphotransferases/*genetics | 2 | 4.0 |
Acid Phosphatase/*metabolism | 2 | 6.0 |
*Chromosomes, Human, 1-3 | 8 | 14.0 |
*Infant, Newborn | 2 | 4.0 |
Blood Protein Electrophoresis | 3 | 2.0 |
HLA Antigens/genetics | 4 | 1.0 |
Recombination, Genetic | 5 | 0.0 |
Blood Group Antigens | 3 | 7.0 |
*Genes, Structural | 5 | 0.0 |
Signal Transduction | 2 | 0.0 |
Complement 6/*genetics | 2 | 14.0 |
*Blood Group Antigens | 5 | 9.0 |
*Isoenzymes | 3 | 18.0 |
*Acid Phosphatase/blood | 2 | 100.0 |
Chromosomes, Human, 1-3 | 2 | 18.0 |
Translocation, Genetic | 2 | 0.0 |
